International Gemmological Institute (India) (IGIL) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
8 Jul, 2026Executive summary
Achieved strong growth in Q2 and H1 CY25, with consolidated certification volumes up 21% YoY in Q2 and 24% YoY in H1, and revenue and EBITDA growth driven by both natural and lab-grown diamond certification.
Maintained leadership in India with over 50% market share and 65%-70% global share in lab-grown diamond certification.
Expanded to 10 countries with 31 labs and 18 gemology schools, and incorporated a new Dubai subsidiary.
Digital transformation and AI investments underway to enhance service delivery and efficiency.
Unaudited standalone and consolidated financial results for Q2 and H1 2025 were approved and reviewed without qualification by auditors.
Financial highlights
Q2 CY25 consolidated certification revenue: INR 2,921 Mn (+18% YoY); H1 CY25: INR 5,888 Mn (+14% YoY); Q2 EBITDA: INR 1,735 Mn (+37% YoY, margin 57.7%); H1 EBITDA: INR 3,692 Mn (+23% YoY, margin 61.0%).
Q2 CY25 PAT: INR 1,265 Mn (+63% YoY, margin 42.0%); H1 CY25 PAT: INR 2,673 Mn (+31% YoY, margin 44.1%).
Standalone revenue for Q2 2025: Rs 2,341.30 million; net profit: Rs 1,374.80 million; for six months, revenue: Rs 4,683.31 million, net profit: Rs 2,766.23 million.
Cash and cash equivalents at June 30, 2025: Rs 126.82 million (standalone), Rs 632.92 million (consolidated).
Volume growth: Q2 CY25 at 3.03 million reports (+21% YoY); H1 CY25 at 6.16 million reports (+24% YoY).
Outlook and guidance
Confident in maintaining 15%-20% revenue growth for CY25, with EBITDA margin guidance of 57%-64%.
IPO proceeds are being utilized as planned, with Rs 13,000 million used for acquisition of IGI Belgium and Netherlands groups and Rs 257.3 million for general corporate purposes.
Expect continued demand for both natural and lab-grown diamond certification, with jewelry segment driving future growth.
No significant changes in demand trends observed in early Q3; business remains stable.
Forward-looking statements highlight risks from market conditions, competition, and execution of strategy.
Latest events from International Gemmological Institute (India)
- Q1 FY27 saw robust revenue and profit growth, driven by strong Indian and global operations.IGIL
Q2 26/27 - High-margin, global certifier expands into colored gemstones, driving growth and diversification.IGIL
Investor Day 2026 presentation - Q1 FY27 saw 23% revenue and 29% EBITDA growth, with strong margins and global momentum.IGIL
Q1 26/27 - Lab-grown diamond certification and acquisitions fueled strong growth and margin expansion.IGIL
Q4 25/26 - Q1 CY2025 saw strong growth in revenue, profit, and margins, led by lab-grown segments.IGIL
Q1 25/26 - Revenue, profit, and margins surged on strong diamond demand and major acquisitions.IGIL
Q4 24/25 - Strong revenue, margin growth, and strategic acquisitions drive robust performance.IGIL
Q3 24/25 - FY24 saw double-digit revenue and profit growth, major acquisitions, and industry-leading margins.IGIL
Q4 23/24 - Q1 2025 saw strong growth in revenue, profit, and margins, led by lab-grown jewelry.IGIL
Q1 24/25